EPISODE · Nov 15, 2024 · 33 MIN
LTR 74: AR/VR devices in MedTech
from Let's Talk Risk! with Dr. Naveen Agarwal · host Where MedTech professionals gain clarity and confidence to navigate complex decisions.
In this Let’s Talk Risk! conversation, Ritam Priya advises device manufacturers to engage early with the FDA through the Q-sub program. Applications of AR/VR in MedTech are growing rapidly, but the regulatory science is still evolving. There are many specific safety and performance concerns unique to AR/VR technologies used for medical purposes. Early engagement with the FDA can help in developing adequate plans for verification and validation of these devices. Image quality, cyber-sickness, rapidly changing hardware and software technologies used in AR/VR applications, for example, are some of the concerns that need careful planning throughout design and development and in the post-market phase. Listen to this Let’s Talk Risk! conversation with Ritam Priya, which also includes an open discussion with a live audience. Jump to a section of interest using these timestamps.00:02:05 Introduction00:01:30 Transitioning into a medical safety role from clinical practice00:02:31 Overview of AR/VR applications in MedTech00:06:15 Example of a recently cleared AR/VR based medical device00:08:27 Image quality is a major concern for FDA in AR/VR devices00:09:20 How FDA is advancing regulatory science for AR/VR technologies00:11:18 Special safety and performance considerations for AR/VR devices00:13:27 Audience Q&A and open discussion00:31:11 Closing comments and key takeawaysIf you enjoyed this podcast, consider subscribing to the Let’s Talk Risk! newsletter.Suggested links:LTR: A fast growing frontier: AR/VR driving innovation in MedTech. FDA: Augmented Reality and Virtual Reality in Medical Devices.About Ritam PriyaRitam Priya is currently the Founder & Principal at Novarum MDRQ Consulting where she provides regulatory consulting services to MedTech clients in both pre- and post-market phases. She has over 20 years of experience in the medical industry, including leadership experience at top organizations. Her expertise includes regulatory requirements for marketing authorization of medical devices in major global markets including US, EU, UK, Australia and Canada. She holds a Bachelor’s degree in Mathematics, Computer Science and Economics, and an MBA in Strategy. Let’s Talk Risk! with Dr. Naveen Agarwal is a weekly live audio event on LinkedIn, where we talk about risk management related topics in a casual, informal way. Join us at 11:00 am EST every Friday on LinkedIn.DisclaimerInformation and insights presented in this podcast are for educational purposes only. Views expressed by all speakers are their own and do not reflect those of their respective organizations. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit naveenagarwalphd.substack.com/subscribe
NOW PLAYING
LTR 74: AR/VR devices in MedTech
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m